课题基金 / 基金详情

项目摘要

项目成果

KENDRITH Martin ROWLAND的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):为了响应RFA-CA-12-007,国家癌症研究所社区临床肿瘤学项目(CCOP),位于伊利诺伊州厄巴纳的卡尔癌症中心正在申请继续资助作为伊利诺伊州中东部CCOP。卡尔癌症中心CCOP由一个主要基地和两个组成部分组成,自1983年CCOP成立以来一直得到持续资助。Carle现在是一家综合医疗保健组织,汇集了一个研究驱动的医疗保健服务网络。该网络的核心是卡尔基金会医院、卡尔医生小组和健康联盟医疗计划。拥有325张床位的一级创伤医院,300多名医生小组和自有的健康保险产品,卡尔CCOP拥有必要的资源,以进一步其研究使命。伊利诺斯州奥罗拉市的拉什科普利医疗中心和印第安纳州密歇根市的方济各会圣安东尼健康中心作为组成机构加入了卡尔CCOP。 集水区共有400多万人,其中130万是少数民族。CCOP的主要研究基地位于伊利诺伊州的厄巴纳,在那里进行所有的注册,随机化,质量保证和数据管理。CCOP的主要研究基地隶属于联盟。此外,卡尔癌症中心CCOP是东部肿瘤协作组(ECOG),国家外科辅助乳腺和肠道项目(NSABP),放射治疗肿瘤组(RTOG),妇科肿瘤组(GOG)和癌症试验支持单位(CTSU)的长期成员。此外,今年春天,卡尔癌症中心CCOP加入了太阳海岸CCOP研究基地。Carle CCOP最近经历了双倍的累积,并完全预期在未来五年内468例治疗受试者和703例癌症对照受试者的累积率。CCOP拥有一支由12名调查员组成的专门研究团队,50多名工作人员,以及互动式行政支持,因此完全有能力取得成功。基于研究驱动的文化,经验丰富和敬业的调查人员,以及无可挑剔的监管标准,Carle CCOP的定位是为它所服务的社区提供最高水平的护理。
英文摘要
DESCRIPTION (provided by applicant): In response to RFA-CA-12-007, Community Clinical Oncology Program (CCOP), National Cancer Institute, the Carle Cancer Center located in Urbana, Illinois is applying for continued funding as an East Central Illinois CCOP. The Carle Cancer Center CCOP, consisting of a main base and two components, has been continually funded since the inception of the CCOP in 1983. Carle, now an integrated healthcare organization, brings together a research-driven network of healthcare services. At the core of this network reside the Carle Foundation Hospital, Carle Physician Group and Health Alliance Medical Plans. With a 325-bed Level I trauma hospital, over 300 physician group, and a self-owned health insurance product, the Carle CCOP possesses the resources necessary to further its research mission. Joining the Carle CCOP as component institutions are Rush-Copley Medical Center in Aurora, Illinois and Franciscan St. Anthony Health in Michigan City, Indiana. Altogether, the catchment area consists of over 4 million people of which 1.3 million are minorities. The CCOP's primary research base is located in Urbana, Illinois where all registration, randomization, quality assurance, and data management are conducted. The CCOP's primary research base affiliation is with Alliance. Additionally, the Carle Cancer Center CCOP is long-standing members of the Eastern Cooperative Oncology Group (ECOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), the Gynecological Oncology Group (GOG), and the Cancer Trials Support Unit (CTSU). Additionally, this past spring, the Carle Cancer Center CCOP joined the SunCoast CCOP Research Base. The Carle CCOP has recently experienced a doubling of accrual and fully anticipates accrual rates of 468 treatment subjects and 703 cancer control subjects over the next five years. With a dedicated research team of 12 investigators, over 50 staff members, and interactive administrative support, the CCOP is well-positioned to succeed. Based on a research-driven culture, seasoned and engaged investigators, and impeccable regulatory standards, the Carle CCOP is positioned to provide the highest level of care to the communities it serves.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/coc.0b013e3182118cdf
发表时间: 2012-08
期刊: American journal of clinical oncology
影响因子: --
作者: [Alberts SR, Fitch TR, Kim GP, Morlan BW, Dakhil SR, Gross HM, Nair S]
通讯作者: Nair S
Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
甲氨蝶呤、长春花碱、阿霉素和顺铂治疗上呼吸道或头颈部消化道鳞状细胞癌患者的 II 期研究。
DOI: 10.1002/cncr.10442
发表时间: 2002
期刊: Cancer.
影响因子: --
作者: [Okuno,ScottH, Mailliard,JamesA, Suman,VeraJ, Edmonson,JohnH, Creagan,EdwardT, Nair,Suresh, Levitt,Ralph, Kugler,JohnW]
通讯作者: Kugler,JohnW
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
多拉司他汀 15 类似物 LU 103793 治疗晚期非小细胞肺癌的 II 期研究。
DOI: 10.1097/01.coc.0000020962.25210.6f
发表时间: 2003
期刊: American journal of clinical oncology : the official publication of the American Radium Society.
影响因子: --
作者: [Marks,RandolphS, Graham,DavidL, Sloan,JeffA, Hillman,Shauna, Fishkoff,Steven, Krook,JamesE, Okuno,ScottH, Mailliard,JamesA, Fitch,TomR, Addo,Ferdinand]
通讯作者: Addo,Ferdinand
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.
评估他莫昔芬加来曲唑在患有转移性乳腺癌的绝经后妇女中的药代动力学相互作用。
DOI: --
发表时间: 1999
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research.
影响因子: --
作者: [Ingle,JN, Suman,VJ, Johnson,PA, Krook,JE, Mailliard,JA, Wheeler,RH, Loprinzi,CL, Perez,EA, Jordan,VC, Dowsett,M]
通讯作者: Dowsett,M
共 7 条
    Carle Cancer Center NCI Community Oncology Research Progran (NCORP)
    • 批准号:
      8901101
    • 项目类别:
    • 资助金额:
      $80.1万
    • 财政年份:
      2014
    • 负责人:
      KENDRITH Martin ROWLAND
    • 依托单位:
    Carle Cancer Center NCI Community Oncology Research Program (NCORP)
    • 批准号:
      10241488
    • 项目类别:
    • 资助金额:
      $214.75万
    • 财政年份:
      2014
    • 负责人:
      KENDRITH Martin ROWLAND
    • 依托单位:
    Carle Cancer Center NCI Community Oncology Research Program (NCORP)
    • 批准号:
      10670223
    • 项目类别:
    • 资助金额:
      $219.83万
    • 财政年份:
      2014
    • 负责人:
      KENDRITH Martin ROWLAND
    • 依托单位:
    Carle Cancer Center NCI Community Oncology Research Progran (NCORP)
    • 批准号:
      8790591
    • 项目类别:
    • 资助金额:
      $91.35万
    • 财政年份:
      2014
    • 负责人:
      KENDRITH Martin ROWLAND
    • 依托单位:
    海外基金